先天性心脏病伴肺动脉高压妊娠问题的研究进展(3)
参考文献
[1] Simonneau G,Robbins I M,Beghetti M,et al.Updated clinical classification of pulmonary hypertension[J].J Am Coll Cardiol,2009,54(1 Suppl):S43-54.
[2] Morrell N W,Adnot S,Archer S L,et al.Cellular and molecular basis of pulmonary arterial hypertension[J].J Am Coll Cardiol,2009,54(1 Suppl):S20-31.
[3] Ma J,Zhang L,Han W,et al.Activation of JNK/c-Jun is required for the proliferation,survival,and angiogenesis induced by EET in pulmonary artery endothelial cells[J].J Lipid Res,2012,53(6):1093-1095.
, http://www.100md.com
[4] Cunningham F G, John C H.WILLIAMS OBSTETRICS[M].22nd Ed.New York:the McGraw-Hill Companies,2005:1017-1042.
[5]陈玲,张婉莹,蒋来,等.妊娠合并心脏病伴肺动脉高压62例临床分析[J].安徽医药,2014,18(1):67-70.
[6]王妍,杨孜,赵扬玉,等.455例妊娠合并心脏病患者不同心功能状况对妊娠结局的影响[J].中国妇产科临床杂志,2009,10(6):430-432.
[7]邵峻,何建国,陈涛,等.6分钟步行距离试验评估合并肺动脉高压的先天性心脏病患者手术效果[J].心肺血管病杂志,2010,29(5):385-387.
[8] George K,Lui M D,Candice K,et al.Heart rate response during exercise and pregnancy outcome in women with congenital heart disease[J].Circ J,2011,123(3):242-248.
, 百拇医药
[9]蔚俊丽,张全斌,高瑞锋,等.超声心动图在妊娠合并心脏病中的诊断价值[J].山西医药杂志,2014,43(4):405-408.
[10]赵静,苏世军.心脏超声Tei指数监测妊娠伴肺动脉高压患者心功能的临床分析[J].宁夏医科大学学报,2013,35(12):1391-1393.
[11] Shinji K,Kaoru Y.Maternal outcome in pregnancy complicated with pulmonary arterial hypertension[J].Circ J,2012,76(9):2249-2254.
[12] Siu S C,Sermer M,Harrison D A,et al.Risk and predictors for pregnancy-related complications in women with heart disease[J].Circ J,1997,96(9):2789-2794.
, http://www.100md.com
[13] Tanous D,Siu S C.B-type natriuretic peptide in pregnant women with heart disease[J].J Am Coll Cardiol,2010,56(15):1247-1253.
[14] Voelkel M A,Wynne K M,Badesch D B,et al.Hyperuricemia in severe pulmonary hypertension[J].Chest,2000,117(1):19-24.
[15]龙雷王,高纪平,祝益民.先心病并发肺动脉高压的评估与治疗[J].中外医学研究,2013,11(4):151-153.
[16] Geohas C,McLaughlin V V.Successful management of pregnancy in a patient with Eisenmenger Syndrome with epoprostenol[J].Chest,2003,124(3):1170-1173.
, 百拇医药
[17] Diller G P,Dimopoulos K,Kaya M G,et al.Long-term safety,tolerability and efficacy of bosentan in adults with pulmonary arterial hypertension associated with congenital heart disease[J].Heart,2007,93(8):974-976.
[18] Sorel Goland,Fausen Tsai,Munira Habib,et al.Favorable outcome of pregnancy with an elective use of epoprostenol and sildenafil in women with severe pulmonary hypertension[J].Cardiology,2010,115(3):205-208.
[19] Robinson J N,Banerjee R,Landzbeng M J,et al.Inhaled nitric oxide therapy in pregnancy complicated by pulmonary hypertension[J].Am J Obstet Gynecol,1999,180(4):1045-1046.
, 百拇医药
[20] Naeije R,Vachiry J L.Medical therapy of pulmonary hypertension Conventional therapies[J].Clin Chest Med,2001,22(3):517-527.
[21] Baumgartner H,Bonhoeffer P,De Groot N M,et al.ESC Guidelines for the management of grown-up congenital heart disease(new version 2010)[J].Eur Heart J,2010,31(23):2915-2957.
[22]景赫,卢家凯.20例妊娠合并艾森曼格综合征剖宫产麻醉管理经验[J].心肺血管病杂志,2012,31(2):113-116.
[23]高志峰,卢家凯.艾森曼格综合症患者剖宫产手术麻醉管理[J].临床麻醉学杂志,2009,25(10):906-907.
, 百拇医药
[24] Hachulla E.Treatment of pulmonary arterial hypertension associated to systemic sclerosis[J].Rev Med Interne,2004,25(3):195-200.
[25]赵永忠.早期干预提高妊娠合并肺动脉高压围术期安全性分析[J].中国临床研究,2013,26(10):39-40.
[26]郝晋红,王惠,刘陶.妊娠合并先天性心脏病房间隔缺损伴肺动脉高压36例临床分析[J].中国循环杂志,2013,28(2):115-117.
[27] Duarte A G,Thomas S,Safdar Z,et al.Management of pulmonary arterial hypertension during pregnancy:a retrospective,multicenter experience[J].Chest,2013,143(5):1330-1336.
(收稿日期:2014-06-20) (编辑:何玉勤), 百拇医药(郝晋红 刘文萃)
[1] Simonneau G,Robbins I M,Beghetti M,et al.Updated clinical classification of pulmonary hypertension[J].J Am Coll Cardiol,2009,54(1 Suppl):S43-54.
[2] Morrell N W,Adnot S,Archer S L,et al.Cellular and molecular basis of pulmonary arterial hypertension[J].J Am Coll Cardiol,2009,54(1 Suppl):S20-31.
[3] Ma J,Zhang L,Han W,et al.Activation of JNK/c-Jun is required for the proliferation,survival,and angiogenesis induced by EET in pulmonary artery endothelial cells[J].J Lipid Res,2012,53(6):1093-1095.
, http://www.100md.com
[4] Cunningham F G, John C H.WILLIAMS OBSTETRICS[M].22nd Ed.New York:the McGraw-Hill Companies,2005:1017-1042.
[5]陈玲,张婉莹,蒋来,等.妊娠合并心脏病伴肺动脉高压62例临床分析[J].安徽医药,2014,18(1):67-70.
[6]王妍,杨孜,赵扬玉,等.455例妊娠合并心脏病患者不同心功能状况对妊娠结局的影响[J].中国妇产科临床杂志,2009,10(6):430-432.
[7]邵峻,何建国,陈涛,等.6分钟步行距离试验评估合并肺动脉高压的先天性心脏病患者手术效果[J].心肺血管病杂志,2010,29(5):385-387.
[8] George K,Lui M D,Candice K,et al.Heart rate response during exercise and pregnancy outcome in women with congenital heart disease[J].Circ J,2011,123(3):242-248.
, 百拇医药
[9]蔚俊丽,张全斌,高瑞锋,等.超声心动图在妊娠合并心脏病中的诊断价值[J].山西医药杂志,2014,43(4):405-408.
[10]赵静,苏世军.心脏超声Tei指数监测妊娠伴肺动脉高压患者心功能的临床分析[J].宁夏医科大学学报,2013,35(12):1391-1393.
[11] Shinji K,Kaoru Y.Maternal outcome in pregnancy complicated with pulmonary arterial hypertension[J].Circ J,2012,76(9):2249-2254.
[12] Siu S C,Sermer M,Harrison D A,et al.Risk and predictors for pregnancy-related complications in women with heart disease[J].Circ J,1997,96(9):2789-2794.
, http://www.100md.com
[13] Tanous D,Siu S C.B-type natriuretic peptide in pregnant women with heart disease[J].J Am Coll Cardiol,2010,56(15):1247-1253.
[14] Voelkel M A,Wynne K M,Badesch D B,et al.Hyperuricemia in severe pulmonary hypertension[J].Chest,2000,117(1):19-24.
[15]龙雷王,高纪平,祝益民.先心病并发肺动脉高压的评估与治疗[J].中外医学研究,2013,11(4):151-153.
[16] Geohas C,McLaughlin V V.Successful management of pregnancy in a patient with Eisenmenger Syndrome with epoprostenol[J].Chest,2003,124(3):1170-1173.
, 百拇医药
[17] Diller G P,Dimopoulos K,Kaya M G,et al.Long-term safety,tolerability and efficacy of bosentan in adults with pulmonary arterial hypertension associated with congenital heart disease[J].Heart,2007,93(8):974-976.
[18] Sorel Goland,Fausen Tsai,Munira Habib,et al.Favorable outcome of pregnancy with an elective use of epoprostenol and sildenafil in women with severe pulmonary hypertension[J].Cardiology,2010,115(3):205-208.
[19] Robinson J N,Banerjee R,Landzbeng M J,et al.Inhaled nitric oxide therapy in pregnancy complicated by pulmonary hypertension[J].Am J Obstet Gynecol,1999,180(4):1045-1046.
, 百拇医药
[20] Naeije R,Vachiry J L.Medical therapy of pulmonary hypertension Conventional therapies[J].Clin Chest Med,2001,22(3):517-527.
[21] Baumgartner H,Bonhoeffer P,De Groot N M,et al.ESC Guidelines for the management of grown-up congenital heart disease(new version 2010)[J].Eur Heart J,2010,31(23):2915-2957.
[22]景赫,卢家凯.20例妊娠合并艾森曼格综合征剖宫产麻醉管理经验[J].心肺血管病杂志,2012,31(2):113-116.
[23]高志峰,卢家凯.艾森曼格综合症患者剖宫产手术麻醉管理[J].临床麻醉学杂志,2009,25(10):906-907.
, 百拇医药
[24] Hachulla E.Treatment of pulmonary arterial hypertension associated to systemic sclerosis[J].Rev Med Interne,2004,25(3):195-200.
[25]赵永忠.早期干预提高妊娠合并肺动脉高压围术期安全性分析[J].中国临床研究,2013,26(10):39-40.
[26]郝晋红,王惠,刘陶.妊娠合并先天性心脏病房间隔缺损伴肺动脉高压36例临床分析[J].中国循环杂志,2013,28(2):115-117.
[27] Duarte A G,Thomas S,Safdar Z,et al.Management of pulmonary arterial hypertension during pregnancy:a retrospective,multicenter experience[J].Chest,2013,143(5):1330-1336.
(收稿日期:2014-06-20) (编辑:何玉勤), 百拇医药(郝晋红 刘文萃)